News

Starting Office-Based Opioid Treatment (OBOT) in Nevada can feel complex, but it doesn’t have to be. This toolkit provides a clear, step-by-step roadmap to help prescribers navigate requirements, establish services, and become ready to prescribe medications for opioid use disorder (MOUD) with confidence. 

The landscape of the United States illicit drug market is shifting with terrifying speed. For several years, public health officials have struggled to contain the “fourth wave” of the opioid crisis, characterized by the adulteration of fentanyl with the veterinary sedative xylazine, commonly known as “tranq.” However, just as harm reduction strategies began to adapt to xylazine, a more potent and dangerous additive has emerged: medetomidine.

As communities mark National Fentanyl Awareness Day today, April 29, experts from the School of Public Health and the Center for the Application of Substance Abuse Technologies (CASAT) are raising awareness about how fentanyl is reshaping the drug supply in Nevada and what can be done to prevent overdose.

A statewide survey is now open to gather community input on Nevada's opioid response. We encourage community members, providers, and partners to participate and help shape efforts across the state.

The Nevada Overdose Data to Action (OD2A) team has released their April 2026 updates, including new monthly surveillance reports and upcoming office hours for partners interested in overdose data.